RAC1 and neoplasm: While in vitro the Rac1-specific 5934 TCR-transduced T cells performed slightly better in cytotoxicity and IFNγ release, the Rac2-specific 22894 TCR-transduced T cells expanded significantly better in vivo and induced more potent regression of the Rac1P29S expressing tumor cells.